Jamaica |
1998 |
The Ministry of Health, Standards and Regulation did not approve registration of the non-steroidal anti-inflammatory drug, ketorolac due to adverse effects. (Reference: Communication to WHO from The Ministry of Health, Standards and Regulation, Kingston, Jamaica 26 September 2000.) |